Seroprevalence of Measles and Mumps Antibodies Among Individuals With Cancer.

ABSTRACT:

Importance

Although patients with cancer are at an increased risk of infection-related complications, few studies have characterized their vulnerability to measles and mumps. Given the recent outbreaks and increased community vaccine hesitancy, understanding measles and mumps immunity within this population is vital.

Objectives

To identify a point prevalence estimate of protective measles and mumps antibodies among ambulatory patients with cancer.

Design, setting, and participants

In this cross-sectional study, residual clinical plasma samples were obtained from consecutive patients with cancer at Seattle Cancer Care Alliance/Fred Hutchinson Cancer Research Center in Seattle, Washington, in August 2019. These samples were tested for measles and mumps IgG using a comme

SUBMITTER: Marquis SR 

PROVIDER: S-EPMC8319758 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature